Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL)

Phase I CARLYSLE study: CAR T-cell therapy obe-cel shows favorable safety and clinical benefit in severe refractory lupus

This article reports initial results from the phase I CARLYSLE study evaluating obecabtagene autoleucel (obe-cel), a CD19-targeting CAR T-ce

ClinicalKey

OHSU advances massive leap in medical science with cellular therapies

Incyte blood cancer drug combo reduces disease-progression risk but with high side-effect rate

GlaxoSmithKline and Genmab submit Arzerra (Ofatumumab) application to FDA for the treatment of advanced stage blood cancer

China approves world's first CAR-T cell therapy for solid tumors: CARsgen's satri-cel for advanced gastric cancer

CARsgen Therapeutics has received approval from China's NMPA for satricabtagene autoleucel (satri-cel; CT041), the world's first CAR-T cell